Issue
Alert me when new journal issues are available via or via
Letter from the editors Leonard M. Freeman, M. Donald Blaufox page 77 Full-Text PDF (43 KB)
Guest editorial Stanley J. Goldsmith page 78 Full-Text PDF (113 KB)
Radiolabeled peptides in diagnosis and tumor imaging: Clinical overview Richard R.P. Warner, Thomas M. O'Dorisio pages 79-83 Abstract | Abstract + References | Full-Text PDF (512 KB)
Somatostatin receptor imaging Dik J. Kwekkeboom, Eric P. Krenning pages 84-91 Abstract | Abstract + References | Full-Text PDF (2019 KB)
Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide Yusuf Menda, Daniel Kahn pages 92-96 Abstract | Abstract + References | Full-Text PDF (1985 KB)
Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies Thomas M. Behr, Martin P. Béhé pages 97-109 Abstract | Abstract + References | Full-Text PDF (4653 KB)
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience Roelf Valkema, Marion de Jong, Willem H. Bakker, Wout A.P. Breeman, Peter P.M. Kooij, Pieternella J. Lugtenburg, Frank H. de Jong, Arjan Christiansen, Boen L.R. Kam, Wouter W. de Herder, Mats Stridsberg, Jan Lindemans, Geert Ensing, Eric P. Krenning pages 110-122 Abstract | Abstract + References | Full-Text PDF (2654 KB)
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies Lowell B. Anthony, Eugene A. Woltering, Gregory D. Espenan, Michele D. Cronin, Tom J. Maloney, Kevin E. McCarthy pages 123-132 Abstract | Abstract + References | Full-Text PDF (791 KB)
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings Marion de Jong, Roelf Valkema, Francois Jamar, Larry K. Kvols, Dik J. Kwekkeboom, Wout A.P. Breeman, Willem H. Bakker, Chuck Smith, Stanislas Pauwels, Eric P. Krenning pages 133-140 Abstract | Abstract + References | Full-Text PDF (1799 KB)
Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide: The experience of the european institute of oncology group Marco Chinol, Lisa Bodei, Marta Cremonesi, Giovanni Paganelli pages 141-147 Abstract | Abstract + References | Full-Text PDF (2391 KB)
111In- and 90Y-DOTA-Lanreotide: Results and implications of the MAURITIUS trial Irene Virgolini, Keith Britton, John Buscombe, Roy Moncayo, Giovanni Paganelli, Pietro Riva pages 148-155 Abstract | Abstract + References | Full-Text PDF (1936 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
